Pfizer honors MSU professor for work with staph bacteria
EAST LANSING, Mich. â€" An MSU assistant professor in the Department of Medicine is one of nine investigators nationwide to receive Pfizer's 2009 Young Investigator Antibacterial Research Awards.
(Media-Newswire.com) - EAST LANSING, Mich. — An MSU assistant professor in the Department of Medicine is one of nine investigators nationwide to receive Pfizer's 2009 Young Investigator Antibacterial Research Awards.
Apoorv Kalra studies linezolid, an antibiotic made by Pfizer, and its impact on bacteria called Staphylococcus aureus, the most common cause of staph infections. Kalra's research program was selected by Pfizer for further funding.
He focuses on linezolid's effect on the bacteria as it pertains to invading human cells, comparing it to other treatments and whether the drug can prevent the bacteria from synthesizing in the body.
MSU's Department of Medicine, led by Mary Nettleman, is part of MSU's College of Human Medicine. For more information, go to http://humanmedicine.msu.edu/.
###
Michigan State University has been advancing knowledge and transforming lives through innovative teaching, research and outreach for more than 150 years. MSU is known internationally as a major public university with global reach and extraordinary impact. Its 17 degree-granting colleges attract scholars worldwide who are interested in combining education with practical problem solving.
Related Content
Published by:
N/A
Release Date
This story was released on 2010-03-17. Please make sure to visit the official company or organization web site to learn more about the original release date. See our disclaimer for additional information.